SynsoryBio
"If-then" conditional logic for protein drugs
Boston, US
Synthetic BiologyBiotechTherapeuticsOncology
SynsoryBio is creating next generation, protein therapeutics that sense where they are in the body and only activate at diseased tissue. This technology platform has the potential to expand the therapeutic window of highly potent drugs and apply to many diseases such as cancer and autoimmune disorders.
Meet the team2
The people behind SynsoryBio
Elliot Tague
Founder
Nathan Tague
Founder